Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
70 participants
OBSERVATIONAL
2005-05-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
NCT04036045
Late Effects of Treatment for Sarcomas in Children
NCT00006515
Project: Every Child for Younger Patients With Cancer
NCT02402244
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
NCT00107458
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
NCT00003750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary aims are to define the natural history of untreated cardiac tumors, study the pathology of primary cardiac tumors, review the surgical treatment and results of primary cardiac tumors and to determine the prognosis for these tumors. The secondary aims are to discover patterns and consistencies among primary cardiac tumors and to define the best treatment options for these patients. The study will be conducted through a retrospective chart review of about 70 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children who have been treated for a primary cardiac tumor
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Healthcare of Atlanta
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Kogon, MD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.